A monoclonal antibody to tumor necrosis factor alpha modify metabolic activity in lymphocytes from rat’s exposed chronic ethanol consumption
Author(s) -
M. V. Haretskaya,
В. М. Шейбак
Publication year - 2013
Publication title -
biomeditsinskaya khimiya
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.192
H-Index - 15
eISSN - 2310-6972
pISSN - 2310-6905
DOI - 10.18097/pbmc20135904425
Subject(s) - monoclonal antibody , tumor necrosis factor alpha , ethanol , infliximab , antibody , tumor necrosis factor α , necrosis , monoclonal , chemistry , pharmacology , alpha (finance) , medicine , endocrinology , immunology , biochemistry , surgery , construct validity , patient satisfaction
Administration of infliximab (a monoclonal antibody to tumor necrosis factor-a 1-10 mg/kg for 10 days) to Wistar rats consuming ethanol for 10 weeks significantly changed levels of free amino acids and their nitrogenous metabolites in liver lymphocytes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom